<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00949195</url>
  </required_header>
  <id_info>
    <org_study_id>SZTE PULM-PAHP</org_study_id>
    <secondary_id>ISRCTN11034505</secondary_id>
    <nct_id>NCT00949195</nct_id>
  </id_info>
  <brief_title>Pulmonary Arterial Pressure Response During Exercise</brief_title>
  <acronym>PAPCOPDHS</acronym>
  <official_title>Pulmonary Arterial Pressure Response During Exercise in COPD and Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Szeged University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Szeged University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background:

      The extent of increase in systolic pulmonary arterial pressure (PAPs) during exercise in
      patients with COPD is unpredictable from lung function data. The non-invasive assessment of
      pulmonary hemodynamics during exercise and flow-mediated vasodilatation measurement may give
      useful data in the rehabilitation of COPD patients.

      Methods:

      Patients with stable, severe COPD and healthy, age-matched subjects (H) perform semi supine
      echocardiography with PAPs measurement. COPD patients perform ramp protocol with gas exchange
      detection. Serum hsCRP level is also determined in COPD patients. Endothel dysfunction is
      detected by flow mediated vasodilation measurement after arm strangulation with Doppler
      ultrasonography.

      Primary endpoint:

      The degree of pulmonary artery systolic pressure change during exercise?

      Secondary endpoint:

        1. The degree of right ventricular function change during exercise?

        2. Is endothel dysfunction manifested with pulmonary artery pressure rise?

        3. What is the correlation between the systemic inflammatory marker hsCRP and the degree of
           pulmonary artery pressure rise?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: The extent of increase in systolic pulmonary arterial pressure (PAPs) during
      exercise in patients with COPD is unpredictable from lung function data. The non-invasive
      assessment of pulmonary hemodynamics during exercise by semi-supine echocardiography and
      flow-mediated vasodilatation measurement may give useful data in the rehabilitation of COPD
      patients.

      Methods: Patients with stable, severe COPD and healthy, age-matched subjects (H) perform semi
      supine echocardiography with PAPs measurement. COPD patients perform ramp protocol with gas
      exchange detection. Serum hsCRP level is also determined in COPD patients. All of the
      subjects perform complete lung function with body pletysmography and diffusion capacity
      measurement. Endothel dysfunction is detected by flow mediated vasodilation measurement after
      arm strangulation with Doppler ultrasonography.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date>December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The degree of pulmonary artery pressure change during exercise?</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Right ventricular function change? Correlation between systemic inflammation (hsCRP) and pulmonary artery pressure change? Endothelial dysfunction?</measure>
    <time_frame>2 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>COPD Patients</condition>
  <condition>Healthy Subjects</condition>
  <condition>Semi-supine Echo (SSE)</condition>
  <condition>Flow-mediated Vasodilatation (FMD)</condition>
  <condition>High Sensitive C-reactive Protein (hsCRP)</condition>
  <arm_group>
    <arm_group_label>COPD patients</arm_group_label>
    <description>COPD patients with severe obstruction performed the tests.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <description>Age-matched healthy subjects performed the same test also.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Measure pulmonary artery pressure change during exercise</intervention_name>
    <description>Semi-supine echocardiography test</description>
    <arm_group_label>COPD patients</arm_group_label>
    <arm_group_label>Healthy subjects</arm_group_label>
    <other_name>lung function, CPX, HsCRP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pulmonary pressure response during exercise</intervention_name>
    <description>Semi-supine echocardiography test</description>
    <arm_group_label>COPD patients</arm_group_label>
    <arm_group_label>Healthy subjects</arm_group_label>
    <other_name>Complete lung function, CPX, HsCRP</other_name>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample is taken to analyse the systemic inflammatory marker (hsCRP) level from serum.
      We measure the samples and than we don't store it.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        COPD patients (age between 45 and 70) with moderate to severe obstruction (FEV1&lt;60%) and
        healthy subjects (age between 45 and 70)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  COPD patients (age between 45 and 70)

          -  with moderate to severe obstruction (FEV1&lt;60%pred) and

          -  healthy subjects (age between 45 and 70, (FEV1&gt;80%pred, FEV1/FVC&gt;70%

        Exclusion Criteria:

          -  Not in the age range

          -  Different FEV1 value

          -  Severe comorbidities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Attila Somfay, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pulmonology, Szeged University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Attila Somfay, MD, PhD</last_name>
    <phone>+36-62-571-551</phone>
    <email>somfay@deszk.szote.u-szeged.hu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Janos Varga, MD</last_name>
    <phone>+36-62-571-527, +36209204235</phone>
    <email>janosvargaster@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Pulmonology, Szeged University</name>
      <address>
        <city>Deszk</city>
        <state>Csongrad County</state>
        <zip>6772</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Attila Somfay, MD, PhD</last_name>
      <phone>+36-62-571-552</phone>
      <email>somfay@deszk.szote.u-szeged.hu</email>
    </contact>
    <contact_backup>
      <last_name>Janos Varga, MD</last_name>
      <phone>+36-62-571-527, +36209204235</phone>
      <email>janosvargaster@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Attila Somfay, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Janos Varga, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Imre Lajko, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2009</study_first_submitted>
  <study_first_submitted_qc>July 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2009</study_first_posted>
  <last_update_submitted>July 20, 2011</last_update_submitted>
  <last_update_submitted_qc>July 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2011</last_update_posted>
  <responsible_party>
    <name_title>Attila Somfay, MD, PhD; Department Leader</name_title>
    <organization>Department of Pulmonology, Szeged University</organization>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>healthy patients</keyword>
  <keyword>PAP</keyword>
  <keyword>CPX</keyword>
  <keyword>SSE</keyword>
  <keyword>hsCRP</keyword>
  <keyword>FMD</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

